Accessibility Menu

Cencora(FRA) ABG

Market Cap€52.48BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPON/A
5 YearN/A
1 YearN/A
1 MonthN/A
€275.00
+0.73%
+2.00Today

Cencora Financials at a Glance

Market Cap

€52.48BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

€285.35K

Net Income (TTM)

€2.26K

EPS (TTM)

€11.53

P/E Ratio

23.85

Dividend

€2.06

Beta (Volatility)

0.07 (Low)

Price

€275.00

Volume

0

Open

€275.00

Previous Close

€275.00

Daily Range

€275.00 - €275.00

52-Week Range

€212.90 - €327.10

Estimated Earnings Date

N/A

ABG News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cencora

AmerisourceBergen Corp. engages in the provision of pharmaceutical products and business solutions that improve access to care. It operates through the Pharmaceutical Distribution Services and Other segments. The Pharmaceutical Distribution Services segment distributes an offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, and long-term care and alternate site pharmacies. The Other segment focuses on global commercialization services and animal health, and includes AmerisourceBergen Consulting Services ABCS, World Courier, and MWI. The company was founded by in Emil P. Martini in 1947 and is headquartered in Conshohocken, PA.

Industry

Healthcare Providers and Services

Sector

Health Care

Employees

51,000

CEO

Robert P. Mauch, PhD

Website

www.cencora.com

ABG Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

103.31%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

4.19%

Dividend Yield

0.75%

Payout Ratio

N/A

Stock Overview

Market Cap

€52.48BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

190.83M

Volume

0

Avg. Volume

2.03

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Cencora Performance Analysis

Cencora annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-09-30EUR 220,623,992,12523.2%
20232023-09-30EUR 245,969,535,37011.5%
20242024-09-30EUR 271,188,873,84910.3%
20252025-09-30EUR 291,052,029,3447.3%
Cencora annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-09-30EUR 7.4420.3%
20232023-09-30EUR 8.007.6%
20242024-09-30EUR 6.95-13.1%
20252025-09-30EUR 7.213.7%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

€72.89K

+1.0%

Gross Profit

€2.87K

+1.2%

Gross Margin

3.93%

+1.2%

Market Cap

€52.48BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

€0.93

N/A

Employees

51,000

N/A

Net Income

€667.98

+1.1%

EBITDA

€1.27K

+1.2%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

€12.76K

+42.4%

Total Debt

€10.25K

+1.5%

Accounts Receivable

€22.26K

+1.1%

Inventory

€18.39K

+1.1%

Long Term Debt

€10.01K

+1.5%

Short Term Debt

€244.17

+1.5%

Return on Assets

3.30%

+1.2%

Return on Invested Capital

24.80%

-10.8%

Free Cash Flow

€2.08K

-22.6%

Operating Cash Flow

€2.28K

+42.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,684.24-0.00%
^DJIDJI
$53,254.61-0.01%
^IXICNASDAQ
$26,319.55-0.00%
BTCBitcoin
$78,890.00-0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PCGPG&E
$13.27-0.20%
NVDANvidia
$220.78+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.97+0.11%
CNHCNH Industrial
$11.83+0.01%

Questions About ABG

What is the current price of Cencora?

Cencora is trading at €275.00 per share.

What is the 52-week range for Cencora?

Over the past 52 weeks, Cencora has traded between €212.90 and €327.10.

How much debt does Cencora have?

As of the most recent reporting period, Cencora reported total debt of €10.25B.

How much cash does Cencora have on hand?

Cencora reported €2.51B in cash and cash equivalents in its most recent financial results.

What is Cencora’s dividend yield?

Cencora currently has a dividend yield of 0.75%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services